When should products be tested in the biotechnology industry?

Testing products in the biotechnology industry before they are sold is essential to ensure safety, efficacy, and compliance with regulatory standards. This process includes rigorous evaluations and trials to identify any potential risks, side effects, or effectiveness of the product in question. Conducting tests prior to sale is not only a matter of ethical responsibility but also a legal requirement in many jurisdictions to protect public health and ensure high-quality products.

Testing only after products are marketed can lead to serious consequences, including harm to consumers and legal repercussions for the manufacturers. Conducting tests during the initial stages of marketing is insufficient, as it may not provide a comprehensive understanding of the product's safety and effectiveness prior to public exposure. Furthermore, assuming that products derived from natural sources do not require testing can be misleading. While natural products may have a history of safe use, they can still pose risks, or their efficacy must be verified through testing. Thus, the most responsible and legally sound approach is to conduct thorough testing before a biotech product is sold to the public.